She then served as clinical director of the Hepatitis subspecialty clinics for the DC Partnership for HIV/AIDS providing clinical care and management of hepatitis infections in DC community clinics while conducting Clinical and translational research on Hepatitis C and HIV coinfection at the National Institutes of Allergy and Infectious Diseases (NIAID).
She currently holds a director position in clinical research at Gilead Sciences Inc, a biotechnology company in California where her work is focused on developing therapeutics for curing viral hepatitis worldwide. She maintains a faculty position as assistant professor of medicine division of Infectious Disease, Department of Medicine at the University of Maryland, Baltimore and has published over 35 manuscripts in peer reviewed journals.
She remains passionate about providing state of the art care for sickle cell patients particularly children in Nigeria.
384 total views, 1 views today